Shu Hong-Yan, Zhang Wei, Zheng Cong-Cong, Gao Man-Yun, Li Yong-Cun, Wang Yan-Gang
Department of Endocrinology and Metabolic Diseases, Zibo Municipal Hospital, Zibo, China.
Department of Endocrinology and Metabolic Diseases, The Affiliated Hospital of Qingdao University, Qingdao, China.
Front Genet. 2021 Aug 23;12:650077. doi: 10.3389/fgene.2021.650077. eCollection 2021.
We report a single-point variant of low-density lipoprotein receptor () in a Chinese proband with a clinical diagnosis of familial hypercholesterolemia (FH) with a comprehensive functional analysis. Target exome capture-based next-generation sequencing was used for sequencing and identification of genomic variants in the gene. The expression, cellular location, and function of the mutant LDLR were analyzed. Sequencing of in FH patients indicated a point variant of single-base substitution (G < A) at a position of 2389 in the 16th exon, which led to a loss of the 16th exon in the messenger RNA. This genomic variant was found to cause exon 16 deletion in the mutant LDLR protein. Subsequent functional analyses showed that the mutant LDLR was retained in the Golgi apparatus and rarely expressed in the cellular membranes of HepG2 cells. Accordingly, the intake ability of HepG2 cells with the mutant LDLR was significantly reduced ( < 0.05). In conclusion, our results suggest that a mutant with a single-base substitution (c. 2389G > A) in the 16th exon of the gene was associated with miscleavage of messenger RNA and the retention of mutant LDLR in the Golgi apparatus, which revealed a pathogenic variant in LDLR underlying the pathogenesis of FH.
我们报告了一名临床诊断为家族性高胆固醇血症(FH)的中国先证者中低密度脂蛋白受体(LDLR)的单点变异,并进行了全面的功能分析。基于目标外显子捕获的新一代测序用于对LDLR基因中的基因组变异进行测序和鉴定。分析了突变型LDLR的表达、细胞定位和功能。对FH患者的LDLR测序表明,第16外显子2389位存在单碱基替换(G>A)的点变异,导致LDLR信使RNA中第16外显子缺失。发现该基因组变异导致突变型LDLR蛋白中第16外显子缺失。随后的功能分析表明,突变型LDLR保留在高尔基体中,在HepG2细胞的细胞膜中很少表达。因此,具有突变型LDLR的HepG2细胞的摄取能力显著降低(P<0.05)。总之,我们的结果表明,LDLR基因第16外显子中的单碱基替换(c.2389G>A)突变与信使RNA的错误切割以及突变型LDLR在高尔基体中的保留有关,这揭示了FH发病机制中LDLR的一个致病变异。